Citations (27)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Marco Zucconi, Andrea Galbiati, Fabrizio Rinaldi, Francesca Casoni & Luigi Ferini-Strambi. (2018) An update on the treatment of Restless Legs Syndrome/Willis-Ekbom Disease: prospects and challenges. Expert Review of Neurotherapeutics 18:9, pages 705-713.
Read now
Read now
Diego Garcia-Borreguero, Arturo Benitez, Ralf Kohnen & Richard Allen. (2015) Augmentation of restless leg syndrome (Willis-Ekbom disease) during long-term dopaminergic treatment. Postgraduate Medicine 127:7, pages 716-725.
Read now
Read now
Akito Kume. (2014) Gabapentin enacarbil for the treatment of moderate to severe primary restless legs syndrome (Willis-Ekbom disease): 600 or 1,200 mg dose?. Neuropsychiatric Disease and Treatment 10, pages 249-262.
Read now
Read now
Articles from other publishers (24)
Sandra Iskandar, Marina Souto Martins, Andrew Hudson, Jason G. Hirsch & Jonathan S. Jahr. (2022) Does Dexmedetomidine Improve or Worsen Restless Leg Syndrome under Sedation: A Case Report and Extensive Review. Case Reports in Critical Care 2022, pages 1-5.
Crossref
Crossref
Yuichi Inoue, Koichi Hirata, Yuya Hoshino & Yusuke Yamaguchi. (2021) Difference in background factors between responders to gabapentin enacarbil treatment and responders to placebo: pooled analyses of two randomized, double-blind, placebo-controlled studies in Japanese patients with restless legs syndrome. Sleep Medicine 85, pages 138-146.
Crossref
Crossref
Qing Lv, Xinlin Wang, Tetsuya Asakawa & Xiao Ping Wang. (2021) Pharmacologic Treatment of Restless Legs Syndrome. Current Neuropharmacology 19:3, pages 372-382.
Crossref
Crossref
E.A. Katunina, N.V. Titova, D.A. Katunin, S.D. Bagmanyan & A.R. Pogorova. (2021) Restless legs syndrome. Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova 121:2, pages 106.
Crossref
Crossref
Valérie Cochen De Cock. (2019) Therapies for Restless Legs in Parkinson’s Disease. Current Treatment Options in Neurology 21:11.
Crossref
Crossref
N. Limousin, M. Flamand, C. Schröder & C. Charley Monaca. (2019) Traitement du syndrome des jambes sans repos nouvellement diagnostiqué. Médecine du Sommeil 16:2, pages 106-113.
Crossref
Crossref
Ningyuan Zhang, Yunfei Li, Yinghua Lv, Ling Xu, Junchao Chen, Hongxia Liu, Lujin Li & Qingshan Zheng. (2019) Quantitative Comparison of the Efficacies of 5 First‐Line Drugs for Primary Restless Leg Syndrome. The Journal of Clinical Pharmacology.
Crossref
Crossref
Imad Ghorayeb. 2019. Pharmacology of Restless Legs Syndrome (RLS). Pharmacology of Restless Legs Syndrome (RLS)
207
235
.
Aaro V. Salminen & Juliane Winkelmann. (2018) Restless Legs Syndrome and Other Movement Disorders of Sleep—Treatment Update. Current Treatment Options in Neurology 20:12.
Crossref
Crossref
N. Limousin, M. Flamand, C. Schröder & C. Charley Monaca. (2018) French consensus: Treatment of newly diagnosed restless legs syndrome. Revue Neurologique 174:7-8, pages 515-521.
Crossref
Crossref
Juliane Winkelmann, Richard P. Allen, Birgit Högl, Yuichi Inoue, Wolfgang Oertel, Aaro V. Salminen, John W. Winkelman, Claudia Trenkwalder & Cristina Sampaio. (2018)
Treatment of restless legs syndrome: Evidence-based review and implications for clinical practice (Revised 2017)
§
. Movement Disorders 33:7, pages 1077-1091.
Crossref
Crossref
I. H. Iftikhar, L. Alghothani & L. M. Trotti. (2017) Gabapentin enacarbil, pregabalin and rotigotine are equally effective in restless legs syndrome: a comparative meta-analysis. European Journal of Neurology 24:12, pages 1446-1456.
Crossref
Crossref
Daniel L. Picchietti, Stephen K. Van Den Eeden, Yuichi Inoue & Klaus Berger. (2017) Achievements, challenges, and future perspectives of epidemiologic research in restless legs syndrome (RLS). Sleep Medicine 31, pages 3-9.
Crossref
Crossref
Esther S. Kim & Emma D. Deeks. (2016) Gabapentin Enacarbil: A Review in Restless Legs Syndrome. Drugs 76:8, pages 879-887.
Crossref
Crossref
Neal Hermanowicz, Aaron Ellenbogen, Gordon Irving, Mark Buchfuhrer, Mark J. Jaros, Gwendoline Shang & Richard Kim. (2016) The Effect of Gabapentin Enacarbil on Pain Associated with Moderate-to-Severe Primary Restless Legs Syndrome in Adults: Pooled Analyses from Three Randomized Controlled Trials. CNS Drugs 30:5, pages 443-454.
Crossref
Crossref
Alon Y. Avidan, Daniel Lee, Margaret Park, Mark J. Jaros, Gwendoline Shang & Richard Kim. (2016) The Effect of Gabapentin Enacarbil on Quality of Life and Mood Outcomes in a Pooled Population of Adult Patients with Moderate-to-Severe Primary Restless Legs Syndrome. CNS Drugs 30:4, pages 305-316.
Crossref
Crossref
Daniel O. Lee, Mark J. Buchfuhrer, Diego Garcia-Borreguero, Alon Y. Avidan, Mansoor Ahmed, Ryan Hays, William G. Ondo, Mark J. Jaros, Richard Kim & Gwendoline Shang. (2016) Efficacy of gabapentin enacarbil in adult patients with severe primary restless legs syndrome. Sleep Medicine 19, pages 50-56.
Crossref
Crossref
Guang Jian Liu, Lang Wu, Song Lin Wang, Li Ding, Li Li Xu, Yun Fu Wang & Li Ying Chang. (2016) Incidence of Augmentation in Primary Restless Legs Syndrome Patients May Not Be That High. Medicine 95:2, pages e2504.
Crossref
Crossref
Birgit Högl & Cynthia Comella. (2015) Therapeutic advances in restless legs syndrome (RLS). Movement Disorders 30:11, pages 1574-1579.
Crossref
Crossref
Claudia Trenkwalder, Juliane Winkelmann, Yuichi Inoue & Walter Paulus. (2015) Restless legs syndrome—current therapies and management of augmentation. Nature Reviews Neurology 11:8, pages 434-445.
Crossref
Crossref
William G. Ondo. (2014) Restless Legs Syndrome: Pathophysiology and Treatment. Current Treatment Options in Neurology 16:11.
Crossref
Crossref
Prachaya Srivanitchapoom, Sanjay Pandey & Mark Hallett. (2014) Restless legs syndrome and pregnancy: A review. Parkinsonism & Related Disorders 20:7, pages 716-722.
Crossref
Crossref
Jin Seo YangYong Jun ChoSuk Hyung KangHyuk Jai Choi. (2014) Demographic and Clinical Characteristics of Patients with Restless Legs Syndrome in Spine Clinic. Journal of Korean Neurosurgical Society 55:2, pages 83.
Crossref
Crossref
Maria Davy, James Upward, Thangam Arumugham, Colleen Twomey, Chao Chen & Brendt Stier. (2013) Cardiac Repolarization With Gabapentin Enacarbil in a Randomized, Double-Blind, Placebo- and Active-Controlled, Crossover Thorough QT/QTc Study in Healthy Adults. Clinical Therapeutics 35:12, pages 1964-1974.
Crossref
Crossref